Fractional Chief Innovation Officer
Executive ownership of innovation portfolio, operating model and governance.
Global R&D Advisory
Turn deep science into defensible categories, durable margins and growth that compounds.
Former VP Research & Innovation and Management Committee member for L’Oréal SAPMENA, with 25+ years across P&G, Marico, L’Oréal and founder-led D2C operations.
€2.9Bnlargest business influenced
€150Mannual R&I allocation directed
50markets at SAPMENA scale
90+countries across career
Mandate fit
Where global R&D leadership creates value
- Beauty, personal care, wellness and consumer-health innovation strategy
- Formulation platform design, claims, performance and product architecture
- Premiumization, category creation and portfolio transformation
- CDMO qualification, supplier capability and technology transfer
- R&D productivity, cycle-time reduction and governance
- Emerging-market adaptation across premium, masstige and mass portfolios
Operating lens
Science → consumer relevance → platform → category → premiumization → share growth → margin expansion → enterprise value.
Commercial scale figures describe businesses and portfolios influenced or led, not owned P&L, except founder ventures.
Relevant engagement formats
R&D turnaround
Cycle time, pipeline quality, organisation capability and capital allocation.
Scientific diligence
Technical and commercial evaluation for investors, boards and strategic buyers.